Fludeoxyglucose F-18 Injection
Product Images NDC 24450-647

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F-18 (NDC 24450-647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Brigham And Women`s Hospital, Inc., The, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Chemical Structure (Chemical Structure)

FDA Label Image

Drug Product Label (Fdglabel)

Drug Product Label (Fdglabel)
This is a description of a multiple-dose vial of Fludeoxyglucose F-18 injection, a diagnostic radiopharmaceutical used for intravenous use only. The manufacturer is Brigham & Women's Hospital, and the lot number is 18FFDG1205244. The calibration is 4890.00 mCi at 0 velocity, and the concentration is between 20 and 300 mCi/mL. The expiration time is 12 hours after the end of synthesis. There is also a warning that the dispensing of this product is prohibited without a prescription due to U.S. law.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.